Intradermal testing is a reliable method of determining the drug or drugs responsible for an anaphylactic reaction.1 Adequate explanation and documentation given to the patient can be effective in preventing subsequent reactions.2 The case of a patient who had a second lifethreatening reaction despite these precautions is described.
FisherMMcD. The diagnosis of acute anaphylactoid reactions to anaesthetic drugs. Anaesth Intens Care1981; 9: 235–241.
2.
FisherMMcD. The prevention of second anaphylactoid reactions to anaesthetic drugs. Anaesth Intens Care1981; 9: 242–246.
3.
CharlesworthJ.A., QuinJ.W., MacDonaldG.J., LenaneR.J., BoughtonC.R.Complement, lymphotoxins and immune complexes in infectious mononucleosis: Serial studies on uncomplicated cases. Clin Exp Immunol1978; 34: 241–247.
4.
BradslundK., SierstedH.I., SvehagS., TeisnerB.Double decker rocket immunophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma. J Immunol Methods1981 (in press).
5.
FisherMMcD. Reaginic antibodies to anaesthetic drugs. Anesthesiology1980; 52: 318–320.
6.
LimM., Churchill-DavidsonH.C.Adverse effects of neuromuscular blocking drugs in Monographs. In: Anaesthesiology No. 8. Adverse Reactions to anaesthetic drugs.ThorntonJ.A., ed. Elsevier, Holland, 1981; 71.
7.
AssemE.S.K., FrostP.G., LevisR.O.Anaphylactic-like reaction to suxamethonium. Anaesthesia1981; 405–410.
8.
LongG.T.Reactions to gallamine. Anaesth Intens Care1979; 7: 191–192.
9.
FisherMMcD, MoreD.G.The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaesth Intens Care1981; 9: 220–234.
